This announcement is a separate document:
デ・ウエスタン・セラピテクス研究所：緑内障治療剤「H-1337」の米国後期第II相臨床試験における被験者への投与開始のお知らせ
D. Western Therapeutics Institute: Notice of commencement of administration of the glaucoma drug “H-1337” to test subjects in the late US phase II clinical trial
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.